Lin Shao-Lee
SEC insider (Form 3/4/5 filer). CIK 0001725092. Chief Executive Officer at Cue Biopharma, Inc. (CUE) and 1 other issuer. 15 reported Form 4/5 transactions since Sep 2024; latest on Oct 12, 2026. Located in SOMERVILLE, MA.
Companies Lin Shao-Lee has filed insider reports for
- Cue Biopharma, Inc. (CUE): Director, Officer, Chief Executive Officer
- Surrozen, Inc./DE (SRZN): Director
Lin Shao-Lee
CIK: 0001725092
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Oct 12, 2026CUE
Cue Biopharma, Inc.
SaleDirect10K shares at avg. $27.50$275K - Oct 12, 2026CUE
Cue Biopharma, Inc.
SaleDirect1.1K shares at avg. $28.05$30K - Aug 13, 2026CUE
Cue Biopharma, Inc.
SaleDirect5.4K shares at avg. $27.19$147K - Aug 13, 2026CUE
Cue Biopharma, Inc.
SaleDirect2.4K shares at avg. $28.11$67K - Aug 13, 2026CUE
Cue Biopharma, Inc.
SaleDirect10.5K shares at avg. $29.48$308K - Aug 12, 2026CUE
Cue Biopharma, Inc.
SaleDirect34.2K shares at avg. $26.99$924K - Aug 12, 2026CUE
Cue Biopharma, Inc.
SaleDirect5.8K shares at avg. $27.75$160K - Aug 12, 2026CUE
Cue Biopharma, Inc.
ExerciseDirect109.2K shares- - Jul 9, 2026CUE
Cue Biopharma, Inc.
AwardDirect327.5K shares- - Jun 1, 2026CUE
Cue Biopharma, Inc.
AwardIndirectPre-Funded Warrants (Right to Buy)
90.9K shares at avg. $11.00-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 12, 2026 |  CUE Cue Biopharma, Inc. | Sale | 10,000 | $27.50 | $275,000 | Direct |
| Oct 12, 2026 | CUE Cue Biopharma, Inc. | Sale | 1,087 | $28.05 | $30,490 | Direct |
| Aug 13, 2026 | CUE Cue Biopharma, Inc. | Sale | 5,423 | $27.19 | $147,451 | Direct |
| Aug 13, 2026 | CUE Cue Biopharma, Inc. | Sale | 2,375 | $28.11 | $66,761 | Direct |
| Aug 13, 2026 | CUE Cue Biopharma, Inc. | Sale | 10,460 | $29.48 | $308,361 | Direct |
| Aug 12, 2026 | CUE Cue Biopharma, Inc. | Sale | 34,225 | $26.99 | $923,733 | Direct |
| Aug 12, 2026 | CUE Cue Biopharma, Inc. | Sale | 5,775 | $27.75 | $160,256 | Direct |
| Aug 12, 2026 | CUE Cue Biopharma, Inc. | Exercise | 109,179 | - | $0 | Direct |
| Jul 9, 2026 | CUE Cue Biopharma, Inc. | Award | 327,537 | - | $0 | Direct |
| Jun 1, 2026 | CUE Cue Biopharma, Inc. | Award Pre-Funded Warrants (Right to Buy) | 90,906 | $11.00 | - | Indirect |
1-10 of 15 transactions